Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies
Details for Australian Patent Application No. 2007281684 (hide)
International Classifications
Event Publications
5 March 2009 PCT application entered the National Phase
PCT publication WO2008/019378 Priority application(s): WO2008/019378
22 October 2009 Assignment before Grant
PDL BioPharma, Inc.; Dana-Farber Cancer Institute, Inc. The application has been assigned to Dana-Farber Cancer Institute, Inc.; Facet Biotech Corporation
3 February 2011 Alteration of Name
The name of the applicant has been altered to Dana-Farber Cancer Institute, Inc.; Abbott Biotherapeutics Corp. Amendments
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007281686-System and method for providing hardware virtualization in a virtual machine environment
2007281682-Compositions and methods using antiCS1 antibodies to treat multiple myeloma
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser